Innovations In Cancer |Fall 2020
Showing of 4 results
UH Seidman Cancer Center Opens New Trial with PVSRIPO, a Viral-based Immunotherapy in Combination with Pembrolizumab for Patients with Recurrent GBM
The two therapies may be able to generate a potent and specific anti-tumor response in rGBM patients, given their different but complimentary mechanisms of action - Innovations in Cancer | Fall 2020
Understanding Racial Disparities in Head and Neck Cancer
Study from UH Seidman Cancer Center suggests biological differences in tumors between African-Americans and European-Americans driving differences in outcomes - Innovations in Cancer | Fall 2020
UH Seidman Cancer Center Leads $7.3 Million Multi-Site Trial of Relapse Prevention in ALL
Survival at one year post-stem cell transplant is 100% - Innovations in Cancer | Fall 2020
More Specific Approach to CAR T Cell Therapy Shows Promise for B Cell Cancers
Investigational New Drug (IND) authorization is under way - Innovations in Cancer | Fall 2020
Results are loading...